Sex-based disparities in cardioprotective medication use in adults with diabetes-Reference-Cited by-同舟云学术

Sex-based disparities in cardioprotective medication use in adults with diabetes

Published:2014-11-05 Issue:1 Volume:6 Page:
ISSN:1758-5996
Container-title:Diabetology & Metabolic Syndrome
language:en
Short-container-title:Diabetol Metab Syndr

Author:

Butalia Sonia,Lewin Adriane M,Simpson Scot H,Dasgupta Kaberi,Khan Nadia,Pilote Louise,Johnson Jeffrey A,Ghali William A,Rabi Doreen M

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1186/1758-5996-6-117.pdf

Reference21 articles.

1. Public Health Agency of Canada: Cardiovascular Disease Morbidity, Mortality and Risk Factors Surveillance Information. 2012, [February]; Available from: http://www.phac-aspc.gc.ca/cd-mc/cvd-mcv/cvdmmrf-mmmcvfr-eng.php#2a

2. Haffner SM: Epidemiology of insulin resistance and its relation to coronary artery disease. Am J Cardiol. 1999, 84 (1, Supplement 1): 11-14. 10.1016/S0002-9149(99)00351-3. [doi:10.1016/S0002-9149(99)00351-3]

3. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Heinz Rahn K, Wedel H, Sten Westerling for the HOT Study Group*: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998, 351 (9118): 1755-1762. 10.1016/S0140-6736(98)04311-6.

4. Gæde P, Lund-Andersen H, Parving H-H, Pedersen O: Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes. NEJM. 2008, 358 (6): 580-591. 10.1056/NEJMoa0706245.

5. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, ASCOT Investigators: Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005, 366 (9489): 895-906. 10.1016/S0140-6736(05)67185-1. [doi:10.1016/S0140-6736(05)67185-1]

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world Use and Outcomes of Sodium-Glucose Cotransporter-2 Inhibitors in Adults With Diabetes and Heart Failure: A Population-level Cohort Study in Alberta, Canada;Canadian Journal of Diabetes;2024-07

2. Geschlechtsspezifische Unterschiede in der Progression von diabetischen Nierenerkrankungen;Die Nephrologie;2023-12-02

3. Trimethoprim-sulfamethoxazole prophylaxis during treatment of granulomatosis with polyangiitis with rituximab in the United States of America: a retrospective cohort study;Arthritis Research & Therapy;2023-07-29

4. Care gaps in achieving cholesterol targets in people with diabetes: A population-based study in a universal health care setting;Diabetes Research and Clinical Practice;2022-02

5. In-Hospital Mortality Risk Factor Analysis in Multivessel Percutaneous Coronary Intervention Inpatient Recipients in the United States;Cureus;2021-08-28